Expression of macrophage migration-inhibitory factor is correlated with progression in oral cavity carcinomas

Anticancer Research

Volumn 32, Issue 10, 2012, Pages 4499-4506

  Kindt, Nadège ^a   Lechien, Jér̂ome ^a   Decaestecker, Christine ^b   Rodriguez, Alexandra ^c   Chantrain, Gilbert ^c   Remmelink, Myriam ^d   Laurent, Guy ^a   Gabius, Hans Joachim ^e   Saussez, Sven ^a,c  

^a UNIVERSITY OF MONS   (Belgium)

^b Laboratory of Image Synthesis and Analysis   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytokine; Dysplasia; Head and neck tumors; Immunomodulation; Inflammation; Prognosis; Tumor progression

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SECOND CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; YOUNG ADULT;

EID: 84867774035     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Filleul O, Preillon J, Crompot E, Lechien J and Saussez S: Incidence of head and neck cancers in Belgium: Comparison with worldwide and French data. Bull Cancer 10: 1173-1183, 2011.
2. Kaltner H and Gabius HJ: A toolbox of lectins for translating the sugar code: The galectin network in phylogenesis and tumors. Histol Histopathol 27: 397-416, 2012.
3. Ledeen RW, Wu G, André S, Bleich D, Huet G, Kaltner H, Kopitz J and Gabius HJ: Beyond glycoproteins as galectin counterreceptors: Tumor/effector T-cell growth control via ganglioside GM1. Ann NY Acad Sci 1253: 206-221, 2012.
4. Choufani G, Nagy N, Saussez S, Marchant H, Bisschop P, Burchert M, Danguy A, Louryan S, Salmon I, Gabius HJ, Kiss R and Hassid S: The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers. Cancer 86: 2353-2363, 1999. (Pubitemid 30010378)
5. Saussez S, Cucu DR, Decaestecker C, Chevalier D, Kaltner H, André S, Wacreniez A, Toubeau G, Camby I, Gabius HJ and Kiss R: Galectin-7 (p53-induced gene 1): A new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann Surg Oncol 13: 999-1009, 2006.
6. Saussez S, Decaestecker C, Lorfevre F, Cucu DR, Mortuaire G, Chevalier D, Wacreniez A, Kaltner H, André S, Toubeau G, Camby I, Gabius HJ and Kiss R: High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. Int J Oncol 30: 1109-1117, 2007.
7. Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, André S, Toubeau G, Gabius HJ and Leroy X: Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 52: 483-493, 2008. (Pubitemid 351327984)
8. Saussez S, Decaestecker C, Mahillon V, Cludts S, Capouillez A, Chevalier D, Vet HK, André S, Toubeau G, Leroy X and Gabius HJ: Galectin-3 up-regulation during tumor progression in head and neck cancer. Laryngoscope 118: 1583-1590, 2008.
9. Cludts S, Decaestecker C, Mahillon V, Chevalier D, Kaltner H, André S, Remmelink M, Leroy X, Gabius HJ and Saussez S: Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectins-1, -3 and -7. Anticancer Res 29: 4933-4940, 2009.
10. Saussez S, Decaestecker C, Cludts S, Ernoux P, Chevalier D, Smetana K Jr., André S, Leroy X and Gabius HJ: Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. Anticancer Res 29:59-65, 2009.
11. Saussez S, de Leval L, Decaestecker C, Sirtaine N, Cludts S, Duray A, Chevalier D, André S, Gabius HJ, Remmelink M and Leroy X: Galectin fingerprinting in Warthin's tumors: Lectin-based approach to trace its origin? Histol Histopathol 25: 541-550, 2010.
12. Remmelink M, de Leval L, Decaestecker C, Duray A, Crompot E, Sirtaine N, André S, Kaltner H, Leroy X, Gabius HJ and Saussez S: Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: Divergent profiles with diagnostic potential. Histopathology 58:543-556, 2011.
13. Conroy H, Mawhinney L and Donnelly SC: Inflammation and cancer: Macrophage migration inhibitory factor (MIF): The potential missing link. QJM 103: 831-836, 2010.
14. Flaster H, Bernhagen J, Calandra T and Bucala R: The macrophage migration inhibitory factor-glucocorticoid dyad: Regulation of inflammation and immunity. Mol Endocrinol 21:1267-1280, 2007. (Pubitemid 46984737)
15. Zeng FY, Weiser WY, Kratzin H, Stahl B, Karas M and Gabius HJ: The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration-inhibitory factor. Arch Biochem Biophys 303: 74-80, 1993. (Pubitemid 23212661)
16. Zeng FY, Gerke V and Gabius HJ: Characterization of the macrophage migration inhibitory factor-binding site of sarcolectin and its relationship to human serum albumin. Biochem Biophys Res Commun 200: 89-94, 1994. (Pubitemid 24183577)
17. Bach JP, Rinn B, Meyer B, Dodel R and Bacher M: Role of MIF in inflammation and tumorigenesis. Oncology 75: 127-133, 2008.
18. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W and Bucala R: CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595-606, 2006. (Pubitemid 44529040)
19. McClelland M, Zhao L, Carskadon S and Arenberg D: Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol 174:638-646, 2009.
20. He XX, Chen K, Yang J, Li XY, Gan HY, Liu CY, Coleman TR and Al-Abed Y: Macrophage migration-inhibitory factor promotes colorectal cancer. Mol Med 15: 1-10, 2009.
21. Ren Y, Law S, Huang X, Lee PY, Bacher M, Srivastava G and Wong J: Macrophage migration-inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242: 55-63, 2005. (Pubitemid 40917968)
22. Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y and Wang S: Overexpression of macrophage migration-inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett 261: 147-57, 2008. (Pubitemid 351253721)
23. Cludts S, Decaestecker C, Johnson B, Lechien J, Leroy X, Kindt N, Kaltner H, André S, Gabius HJ and Saussez S: Increased expression of macrophage migration-inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer Res 30: 3313-3319, 2010.
24. Dumitru CA, Gholaman H, Trellakis S, Bruderek K, Dominas N, Gu X, Bankfalvi A, Whiteside TL, Lang S and Brandau S: Tumor-derived macrophage migration-inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 129: 859-869, 2011.
25. Hyams VJ, Batsakis JG and Michaels L: Tumors of the Upper Respiratory Tract and Ear. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington DC: pp. 123-126, 1988.
26. Wittekind C, Greene FL and Hutter RVP: TNM Atlas. 5th ed. UICC Springer: Berlin, pp. 20-32, 2004.
27. Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J, Ernoux-Neufcoeur P, Bletard N, Somja J, Depuydt C, Delvenne P and Saussez S: Human Papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 122: 1558-1565, 2012.
28. Kindt N, Preillon J, Kaltner H, Gabius H-J, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G and Saussez S: Macrophage migration-inhibitory factor in head and neck squamous cell carcinoma: Clinical and experimental studies. Submitted.
29. Papaspyridonos M, McNeill E, de Bono JP, Smith A, Burnand KG, Channon KM and Greaves DR: Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arterioscler Thromb Vasc Biol 28: 433-440, 2008.
30. Demers M, Magnaldo T and St-Pierre Y: A novel function for galectin-7: Promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res 65: 5205-5210, 2005. (Pubitemid 40827330)
31. Park JE, Chang WY and Cho M: Induction of matrix metalloproteinase-9 by galectin 7 through p38 MAPK signaling in HeLa human cervical epithelial adenocarcinoma cells. Oncol Rep 22: 1373-1379, 2009.
32. Saussez S, Cludts S, Capouillez A, Mortuaire G, Smetana K Jr, Kaltner H, André S, Leroy X, Gabius HJ and Decaestecker C: Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7. Int J Oncol 34: 433-439, 2009.